CYP7B1

Cytochrome P450 Family 7 Subfamily B Member 1

Gene Information Card

Symbol CYP7B1
Full Name Cytochrome P450 Family 7 Subfamily B Member 1
Gene Type Protein coding
Chromosomal Location 8q12.3
NCBI Gene ID 9420 ncbi.nlm.nih.gov/gene/9420
Ensembl ID ENSG00000172817
UniProt ID O75881
OMIM ID 603711
HGNC ID 2652
Aliases CP7B, SPG5A, oxysterol 7-alpha-hydroxylase

Description

CYP7B1 encodes a member of the cytochrome P450 superfamily of enzymes, specifically oxysterol 7α-hydroxylase. This enzyme catalyzes the 7α-hydroxylation of oxysterols, including 25-hydroxycholesterol and 27-hydroxycholesterol, playing a critical role in the alternative (acidic) pathway of bile acid synthesis. It is also involved in neurosteroid metabolism, particularly in the brain. Mutations in CYP7B1 cause hereditary spastic paraplegia type 5A (SPG5A), a neurodegenerative disorder characterized by progressive lower limb spasticity and weakness.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Hereditary spastic paraplegia 5A (SPG5A) Loss-of-function mutations impair oxysterol 7α-hydroxylase activity, leading to accumulation of neurotoxic oxysterols (e.g., 27-hydroxycholesterol) in the central nervous system, causing axonal degeneration. ClinVar, OMIM
Bile acid synthesis defect, congenital, 3 Deficient enzyme activity disrupts the alternative bile acid synthesis pathway, resulting in accumulation of atypical bile acids and cholestatic liver disease. OMIM, NCBI Gene

Expression Profile

Tissue Expression
Tissue nTPM level
Liver 12.5 Medium
Brain 8.3 Medium
Adrenal gland 6.1 Low
Kidney 4.7 Low
Testis 3.2 Low
Cell Line Expression
Cell Line nTPM Notes
HepG2 15.0 Hepatocellular carcinoma cell line
SH-SY5Y 9.8 Neuroblastoma cell line
HEK293 5.2 Embryonic kidney cell line
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.889A>G (p.Thr297Ala) Missense Rare Reduced enzyme activity; associated with SPG5A
c.145C>T (p.Arg49*) Nonsense Rare Premature stop codon; loss of function; SPG5A
c.1075C>T (p.Arg359*) Nonsense Rare Loss of function; SPG5A
c.169G>A (p.Gly57Arg) Missense Rare Impaired catalytic activity; SPG5A
Mutation functional classification

Loss of Function (LOF)

Most CYP7B1 mutations are loss-of-function, leading to reduced or absent oxysterol 7α-hydroxylase activity, causing accumulation of oxysterols and bile acid intermediates.

Gain of Function (GOF)

No gain-of-function mutations have been reported for CYP7B1.

Dominant Negative (DN)

No dominant-negative effects have been described for CYP7B1 mutations; inheritance is autosomal recessive.

Gene Ontology (GO)

• oxysterol 7-alpha-hydroxylase activity • iron ion binding
• heme binding • oxidoreductase activity
• acting on paired donors • with incorporation or reduction of molecular oxygen
• steroid hydroxylase activity • endoplasmic reticulum membrane

Pathways

Alternative pathway of bile acid synthesis
Neurosteroid metabolism
Cholesterol metabolism

Protein Summary

CYP7B1 is a 506-amino acid microsomal cytochrome P450 enzyme localized to the endoplasmic reticulum. It catalyzes the 7α-hydroxylation of oxysterols such as 25-hydroxycholesterol and 27-hydroxycholesterol, initiating the acidic pathway of bile acid synthesis. The enzyme is highly expressed in liver and brain, where it also metabolizes neurosteroids. Deficiency due to biallelic mutations leads to accumulation of toxic oxysterols, causing hereditary spastic paraplegia type 5A and, in some cases, congenital bile acid synthesis defects.

Related Products

Product name Cat.No. Species Gene ID
CYP7B1 Knockout HEK293 Cell Line EDJ-KQ2899 Human 9420 Details Get a Quote
CYP7B1 Knockout HeLa Cell Line EDJ-KQ55159 Human 9420 Details Get a Quote
CYP7B1 Knockout A-549 Cell Line EDJ-KQ63639 Human 9420 Details Get a Quote
CYP7B1 Knockout HCT 116 Cell Line EDJ-KQ72101 Human 9420 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: